News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Generex Biotechnology Corporation Engages Dr. Jaime Davidson, MD, FACP, FACE As Medical Director
July 13, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that it has engaged Dr. Jaime Davidson, MD, FACP, FACE as a consultant Medical Director for the Company.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Deals
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
October 15, 2026
·
4 min read
·
Annalee Armstrong
Licensing
Gilead snags equity stake in Vir with up to $1.87B deal for three T cell engagers
October 14, 2026
·
1 min read
·
Annalee Armstrong
Legal
‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban
October 14, 2026
·
4 min read
·
Annalee Armstrong
Layoffs
GSK plans 1.2K+ layoffs at Belgium sites as $2.5B restructure gains momentum
October 14, 2026
·
1 min read
·
Gabrielle Masson